AGP Picks
View all

Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

Press releases published on July 21, 2026

9 in 10 Pet Owners Say Their Pets Are Family. More Than 80% Say Caring for Them Gives Their Day Purpose
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC
New study finds GLP-1 receptor agonists associated with lower risk of alcohol-related hospitalization among adults with alcohol use disorder
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
U.S. House Unanimously Passes DeOndra Dixon INCLUDE Project Act – A Historic Victory for Down Syndrome Research
Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
Flyte Partners with Blade to Expand Vision Jet Distribution
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
Inkoop van eigen aandelen
Acquisition of Own Shares
Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Journal of Oregon

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.